Triangle
AI NativeTriangle helps people navigate complex diagnoses and discover emerging treatments with AI.
Est 2024|Valuation $25M|Raised $4M
Published Oct 13, 2026
No public market share data was identified for Triangle. App store ratings and other public signals indicate an early-stage public footprint.
—
| Aspect | Triangle (official product site and feature pages) | Ciitizen | OpenEvidence |
|---|---|---|---|
| Starting Price | Published consumer and concierge pricing listed by the vendor, including a basic subscription, a one-time concierge option, and a "Core" plan listed as coming soon | Pricing not clearly public in sources reviewed | Marketed for clinicians; consumer pricing not the primary focus |
| Best For | Patients/caregivers needing AI-assisted understanding and option discovery (trials/emerging treatments) | Patients who need help collecting records from providers and organizing them | Clinicians seeking evidence-oriented answers and summaries |
| Key Strength | Integrated workflow: records ingestion → timeline → option exploration; offers a paid concierge review | Operational focus on record retrieval, reducing administrative burden | Evidence-oriented tool for clinicians with journal integration (per vendor materials) |
| Key Weakness | Limited independent reviews; evidence quality depends on implementation; portal sync geographically limited; refund/terms ambiguity | Less focused publicly on emerging treatment discovery vs. record logistics | Not designed for direct patient navigation; requires clinician context for full value |